Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE (Details Narrative)

NOTES PAYABLE (Details Narrative) - USD ($)		1 Months Ended		3 Months Ended		6 Months Ended		12 Months Ended
NOTES PAYABLE (Details Narrative) - USD ($)	Jul. 28, 2020	Nov. 30, 2022	Nov. 30, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Instrument, Unamortized Discount				$ 2,954,390		$ 2,954,390		$ 2,954,390
Interest Expense, Debt				970,000	$ 698,000	1,907,000	$ 1,382,000
Lenders [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Instrument, Unamortized Discount				2,954,000		2,954,000
Insurance Policy [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Prepaid expenses				$ 167,500		$ 167,500		418,750
Loan Agreement [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Notes payable		$ 452,250	$ 984,375
Monthly principal and interest payments		$ 51,387	$ 111,041
Monthly loan payments term		nine-month period	nine-month period
Annual interest rate		5.40%	3.64%
Loan Agreement [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Annual interest rate				13.50%		13.50%
Secured debt				$ 20,715,000		$ 20,715,000
Debt description	The loan matures on August 1, 2024 and the Company is obligated to make interest only payments for the first 24 months and then interest and equal principal payments for the next 24 months commencing on September 1, 2022
Debt conversion amount						$ 875,000		$ 5,000,000
Debt conversion per share				$ 4.50		$ 4.50		$ 282.00
Adjustments to Additional Paid in Capital, increase in fair value of conversion option								$ 573,000
Warrants to purchase shares of common stock, exercised	2,874					194,444
Warrant exercisable price per share	$ 208.80
Proceeds from Warrant Exercises	$ 472,000
Proceeds from prepayment and default features	546,000
Debt issuance cost	1,244,000
Final payment	1,590,000			$ 1,590,000		$ 1,590,000
Loan Agreement [Member] \| K2 HealthVentures LLC [Member] \| Share-Based Payment Arrangement, Tranche One [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Secured debt	$ 20,000,000
Loan Agreement [Member] \| Debt 1 [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt conversion amount								2,000,000
Loan Agreement [Member] \| Debt 1a [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt conversion amount						$ 4,125,000		$ 875,000
Loan Agreement [Member] \| Debt 1a [Member] \| K2 HealthVentures LLC [Member] \| Minimum [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt conversion per share								$ 282.00
Loan Agreement [Member] \| Debt 1a [Member] \| K2 HealthVentures LLC [Member] \| Maximum [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt conversion per share								$ 4.50
Loan Agreement [Member] \| Debt 1b [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt conversion amount								$ 1,125,000
Loan Agreement [Member] \| Debt 1b [Member] \| K2 HealthVentures LLC [Member] \| Minimum [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt conversion per share								$ 282.00
Loan Agreement [Member] \| Debt 1b [Member] \| K2 HealthVentures LLC [Member] \| Maximum [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt conversion per share								$ 7.875
Loan Agreement [Member] \| Debt 2 [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt conversion amount								$ 3,000,000
Amended loan agreement [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt description	The Company entered into an Amendment to the Loan and Security Agreement (the "Amended Loan and Security Agreement") on October 25, 2022. The Amended Loan and Security Agreement defers the commencement of principal repayments by a one-year period from September 1, 2022 to September 1, 2023 and if the Company raises at least $30 million in net proceeds through capital raising transactions, the commencement of principal repayments will be deferred by an additional six months to March 1, 2024. Interest accrues at a variable annual rate equal to the greater of (i) 8.5% and (ii) the rate of interest noted in The Wall Street Journal, Money Rates section, as the “Prime Rate” plus 5.25%, in each case, subject to a step-down of 25 basis points upon the funding of the second tranche
Debt issuance cost	$ 119,000
Event of Default - Loan Agreement [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Annual interest rate				5.00%		5.00%
Debt maturity date						Aug. 01, 2024